SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.80 |
| Enterprise Value ($M) | 1.80 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 23.02 |
| Operating Income | -8.02 |
| Net Income | -8.73 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -9.51 |
| Cash from Investing | -0.36 |
| Cash from Financing | 33.95 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 58,565 | 160,418 | 36.51 | |
| 31,152 | 110,596 | 28.17 | |
| 69,921 | 178,885 | 39.09 | |
| 31,829 | 136,491 | 23.32 | |
| 261,761 | 801,393 | 32.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TSBX – Turnstone Biologics Corp. | TTNP – Titan Pharmaceuticals, Inc. |
| UNCY – Unicycive Therapeutics, Inc. | UPXI – Upexi, Inc. |
| VERU – Veru Inc. |
Financial data and stock pages provided by
Fintel.io